XFOR 0.98 (-6.67%)
US98420X1037BiotechnologyBiotechnology

X4 Pharmaceuticals (XFOR) Stock Highlights

0.98 | -6.67%
2024-05-14 03:17:36
X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. Its product candidate, X4P-001, has completed a Phase 2 trial in patients with a rare genetic PI called Warts. The company is also developing X4P-002, a CXCR4 antagonist that has properties that could enable penetration of the blood-brain barrier and provide appropriate therapeutic exposures to treat brain cancers, including glioblastoma multiforme.

Statistics

Range Today
0.96 1.07
Volume Today 3.27M
Range 1 Year
0.57 2.58
Volume 1 Year 684.75M
Range 3 Year
0.57 9.9
Volume 3 Year 1.06B
Range 10 Year
0.57 172.164
Volume 10 Year 1.13B

Highlights

Market Capitalization 178.85M (small)
Floating Shares 130.2M
Current Price 0.98
Price To Earnings -1.57
Price To Book 175
Earnings Per Share -0.67
Payout Ratio 0%

Performance

Latest -6.67%
1 Month -26.32%
3 Months -1.01%
6 Months +27.27%
1 Year -35.1%
3 Years -88.03%
5 Years -95.36%
10 Years -98.74%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.